|
|
|
Insider
Information: |
Rojkjaer Lisa |
Relationship: |
Chief Medical Officer |
City: |
Cardiff |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
48,087 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$37,075 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
48,087 |
|
|
Total
Value |
$37,075 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Viracta Therapeutics Ord Shs |
VIRX |
Chief Medical Officer |
2023-02-27 |
48,087 |
2021-05-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VIRX |
Viracta Therapeutics Ord ... |
Chief Medical Officer |
|
2023-02-27 |
4 |
S |
$1.68 |
$3,625 |
D/D |
(2,156) |
48,087 |
0 |
% |
|
VIRX |
Viracta Therapeutics Ord ... |
Chief Medical Officer |
|
2023-02-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,127 |
50,243 |
0 |
- |
|
VIRX |
Viracta Therapeutics Ord ... |
Chief Medical Officer |
|
2022-11-28 |
4 |
S |
$2.72 |
$5,754 |
D/D |
(2,116) |
46,116 |
0 |
% |
|
VIRX |
Viracta Therapeutics Ord ... |
Chief Medical Officer |
|
2022-11-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,127 |
48,232 |
0 |
- |
|
VIRX |
Viracta Therapeutics Ord ... |
Chief Medical Officer |
|
2022-08-26 |
4 |
S |
$4.01 |
$8,786 |
D/D |
(2,190) |
44,105 |
0 |
% |
|
VIRX |
Viracta Therapeutics Ord ... |
Chief Medical Officer |
|
2022-08-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,127 |
46,295 |
0 |
- |
|
VIRX |
Viracta Therapeutics Ord ... |
Chief Medical Officer |
|
2022-05-26 |
4 |
S |
$1.90 |
$4,095 |
D/D |
(2,154) |
42,168 |
0 |
% |
|
VIRX |
Viracta Therapeutics Ord ... |
Chief Medical Officer |
|
2022-05-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,127 |
44,322 |
0 |
- |
|
VIRX |
Viracta Therapeutics Ord ... |
Chief Medical Officer |
|
2022-02-28 |
4 |
S |
$2.78 |
$6,657 |
D/D |
(2,395) |
40,195 |
0 |
% |
|
VIRX |
Viracta Therapeutics Ord ... |
Chief Medical Officer |
|
2022-02-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,127 |
42,590 |
0 |
- |
|
VIRX |
Viracta Therapeutics Ord ... |
Chief Medical Officer |
|
2021-05-11 |
4 |
OE |
$1.26 |
$48,567 |
D/D |
34,750 |
34,750 |
0 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|